EuropaBio statement on WTO ruling on biotech crops
The European biotechnology industry, like the European Commission, supports choice - the choice to grow, import and consume approved GM products. The industry continues to back a science-based regulatory system to ensure farmers have the choice to use sustainable techniques that best meet the needs of their farming operations. The EU's regulatory procedure for GM crops sets in place mandatory requirements to ensure that consumers are provided with information that allows them to make informed choices about whether or not to purchase these products. Countries that do not implement the EU rules, which they themselves put in place, are denying that choice.
The dispute over biotech crops is not about safety, the crops being grown around the world have passed stringent food, feed and environmental safety standards and are as safe as, or safer than, conventional crops. The UN Food and Agriculture Organization, The World Health Organization and the European Commission have all found that the approved crop biotechnology products on the market today do not show any risks to human health or the environment.
Since the case was launched in 2003, farmers around the world have been choosing to plant biotech crops at unprecedented rates. Last year alone, more than 90 million hectares were sown with biotech crops by over 8.5 million farmers in 21 countries including European countries - the Czech Republic, France, Germany, Portugal, Romania and Spain.
"Scientists worldwide have shown GM crops to be safe, farmers around the world are increasingly choosing to grow GM crops, the food industry is increasingly supportive and the general public / consumers are increasingly open to it," says Simon Barber, Director of the Plant Biotechnology Unit at EuropaBio - the EU association for bioindustries.
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.